Holen Sie sich die Stockscreener-App
1.61
0.63%
0.01
Handel nachbörslich:
1.58
-0.03
-1.86%
Schlusskurs vom Vortag:
$1.60
Offen:
$1.6
24-Stunden-Volumen:
275.50K
Relative Volume:
0.95
Marktkapitalisierung:
$60.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.63%
1M Leistung:
+14.18%
6M Leistung:
-15.71%
1J Leistung:
-17.44%
1-Tages-Spanne:
$1.523
$1.695
1-Wochen-Bereich:
$1.46
$1.695
52-Wochen-Spanne:
$1.23
$3.95
Metagenomi Therapeutics Inc Stock (MGX) Company Profile
Firmenname
Metagenomi Therapeutics Inc
Sektor
Branche
Telefon
(510) 871-4880
Adresse
5959 HORTON STREET, EMERYVILLE
Compare MGX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGX
Metagenomi Therapeutics Inc
|
1.61 | 60.07M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Metagenomi Therapeutics Inc Stock (MGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-03-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-03-05 | Eingeleitet | TD Cowen | Outperform |
| 2024-03-05 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Metagenomi Therapeutics Inc Aktie (MGX) Neueste Nachrichten
Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates - Nasdaq
Metagenomi Therapeutics: Q4 Earnings Snapshot - kens5.com
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results - Bitget
Metagenomi Therapeutics Q4 Earnings Assessment - Benzinga
MGX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MGX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
MGX Technical Analysis & Stock Price Forecast - Intellectia AI
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference - The Manila Times
Metagenomi Therapeutics, Inc. CEO Jian Irish to Speak at 46th Annual TD Cowen Healthcare Conference - Quiver Quantitative
Gene-editing firm Metagenomi CEO in TD Cowen fireside chat - Stock Titan
MGXMetagenomi Therapeutics, Inc Latest Stock News & Market Updates - Stock Titan
Is Metagenomi Therapeutics (NASDAQ:MGX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Head to Head Analysis: Acusphere (OTCMKTS:ACUS) and Metagenomi (NASDAQ:MGX) - Defense World
Xeris Biopharma (NASDAQ:XERS) and Metagenomi (NASDAQ:MGX) Critical Comparison - Defense World
Metagenomi (NASDAQ:MGX) and UCB (OTCMKTS:UCBJY) Critical Survey - Defense World
These two noteworthy penny stocks can do wonders! Here's more insights into Alto Ingredients, Metagenomi and others - MSN
Aug Sentiment: Why Metagenomi Inc stock could benefit from AI revolutionAnalyst Upgrade & Daily Volume Surge Trade Alerts - moha.gov.vn
Resistance Check: Should I add Metagenomi Inc stock to my portfolioJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Metagenomi changes name, advances hemophilia A gene therapy program By Investing.com - Investing.com Nigeria
Metagenomi advances gene editing therapies into 2025 - MSN
Metagenomi changes name, advances hemophilia A gene therapy program - Investing.com
Metagenomi Therapeutics Rebrands to Emphasize Therapeutic Focus - TipRanks
Metagenomi to submit IND in Q4 2026 to advance MGX-001 into first human studies - TipRanks
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook - The Manila Times
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights ... - bdtonline.com
Gainers Report: Is Metagenomi Inc stock dividend yield sustainableFed Meeting & Weekly Top Performers Watchlists - moha.gov.vn
Is Metagenomi Inc. stock dividend yield sustainableWide Width Options & HOKA model picks for your routine - ulpravda.ru
Operating cash flow per share of Metagenomi, Inc. – NASDAQ:MGX - TradingView — Track All Markets
VIX Spike: Is Metagenomi Inc. stock dividend yield sustainableTrend Reversal & Expert Curated Trade Setups - Улправда
Patterns Watch: Is Metagenomi Inc. stock undervalued vs historical averages2025 Historical Comparison & Consistent Profit Trading Strategies - Улправда
Is Metagenomi Inc. stock positioned well for digital economy2025 Stock Rankings & AI Forecasted Entry and Exit Points - Улправда
Is Metagenomi Inc. stock a defensive play in 2025Earnings Miss & Weekly High Momentum Picks - Улправда
Will Metagenomi Inc. stock attract ESG investors2025 Short Interest & Free AI Powered Buy and Sell Recommendations - Улправда
How interest rate cuts could boost Metagenomi Inc. stock2025 Trading Volume Trends & High Accuracy Investment Entry Signals - ulpravda.ru
Market Overview: Is Metagenomi Inc. stock supported by innovation pipelineWeekly Profit Summary & Expert-Curated Trade Recommendations - ulpravda.ru
Is Metagenomi Inc. stock in correction or buying zoneWeekly Investment Report & Capital Efficiency Focused Ideas - Улправда
Oklahoma City NewsThe OklahomanMetagenomi, Inc.Common Stock (Nasdaq:MGX) Detailed Stock Data - FinancialContent
Is Metagenomi Inc. stock supported by innovation pipelineAnalyst Upgrade & Entry Point Confirmation Alerts - ulpravda.ru
Why Metagenomi Inc. stock attracts global investorsJuly 2025 Summary & Long-Term Capital Growth Ideas - ulpravda.ru
Why Cloudflare, Inc. stock attracts strong analyst attention - Улправда
Is Metagenomi Inc. stock attractive after correctionHigh Beta Stocks & Maximize ROI With Proven Growth Stocks - Улправда
Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Aug Fed Impact: Is Metagenomi Inc stock undervalued vs historical averagesCEO Change & Reliable Breakout Forecasts - moha.gov.vn
Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates - MSN
Head to Head Survey: Madrigal Pharmaceuticals (NASDAQ:MDGL) vs. Metagenomi (NASDAQ:MGX) - Defense World
Short Interest in Metagenomi, Inc. (NASDAQ:MGX) Grows By 27.1% - Defense World
Exit Recap: Is Metagenomi Inc stock supported by innovation pipeline2025 Trading Volume Trends & Fast Moving Stock Trade Plans - moha.gov.vn
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock By Investing.com - Investing.com UK
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock - Investing.com
Metagenomi Earnings Notes - Trefis
CEO Moves: Can Metagenomi Inc stock weather global recession2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - moha.gov.vn
Finanzdaten der Metagenomi Therapeutics Inc-Aktie (MGX)
Es liegen keine Finanzdaten für Metagenomi Therapeutics Inc (MGX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):